🔎 Trials Near Me

Utama › Melanoma › Texas › Dallas

Kajian klinikal Melanoma di Dallas, TX

20 kajian untuk Melanoma sedang mencari peserta di lokasi dalam dan sekitar Dallas (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

DESTINY-PANTUMOUR04

Mengambil pesertaKajian pemerhatian
  • Research Site, Dallas
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Mengambil pesertaFasa 3
  • Texas Oncology - Medical City, Dallas
  • Texas Oncology, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06246916

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Mengambil pesertaFasa 1/2
  • Baylor, Scott and White Research Institute, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mengambil pesertaKajian pemerhatian
  • UT Southwestern Medical Center, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Mengambil pesertaFasa 1/2
  • UT Southwestern, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07288112

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Texas Oncology - Dallas SCRI, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07287917

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Mengambil pesertaFasa 1/2
  • Texas Oncology, P.A., Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06330064

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Mengambil pesertaFasa 1/2
  • Call for Information (Investigational Site 0054), Dallas
6 Months – 17 Years · Semua jantina · Dikemas kini 6 Jul 2026 · NCT02332668

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Mengambil pesertaKajian pemerhatian
  • University of Texas Southwestern Medical Center, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jun 2026 · NCT06400550

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Mengambil pesertaFasa 1/2
  • Mary Crowley Cancer Research, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Mei 2026 · NCT05379985

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Mengambil pesertaFasa 3
  • Texas Retina Associates - Dallas, Dallas
  • University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT07015190

A Study of VET3-TGI in Patients With Solid Tumors

Mengambil pesertaFasa 1
  • Mary Crowley Cancer Research, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Apr 2026 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Mengambil pesertaFasa 2/3
  • UT Southwestern Medical Center, Dallas
Semua umur · Semua jantina · Dikemas kini 2 Apr 2026 · NCT06581406

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Mengambil pesertaFasa 1/2
  • Research Site, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Mac 2026 · NCT06956690

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • NEXT Dallas, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jan 2026 · NCT07317505

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Research Site 120, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Nov 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Dallas
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Mary Crowley Cancer Research, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Okt 2025 · NCT04370587

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • NEXT Oncology, Dallas, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Jan 2024 · NCT05746897

Kajian Melanoma di bandar lain

Kajian lain di Dallas

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.